NCT07160296 Supporting Treatment Resilience With Optimized Nutrition and Guided Exercise in Head and Neck Cancer Patients Undergoing Chemoradiation
| NCT ID | NCT07160296 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Renown Health |
| Condition | Head and Neck Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-09-15 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-09-15 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study to find out whether a structured lifestyle intervention-combining nutrition counseling, guided exercise, and wellness education-can help reduce treatment-related side effects and improve physical function, resilience, and quality of life in patients with head and neck cancer undergoing chemoradiation therapy (chemoRT). Benefits of research cannot be guaranteed but we hope to learn whether this intervention is feasible and acceptable during active cancer treatment, and whether it can help preserve lean body mass, improve strength and endurance, and support emotional well-being. The findings will inform the design of a future larger clinical trial.
Eligibility Criteria
Inclusion Criteria: * Adults ≥18 years old with biopsy-confirmed squamous cell carcinoma of the head and neck * Planned for definitive or adjuvant chemoRT * ECOG performance status 0-2 * Ability to participate in light-to-moderate physical activity * Able to provide informed consent Exclusion Criteria: * Severe malnutrition requiring exclusive enteral feeding at baseline * Comorbidities that preclude safe participation in exercise * Cognitive or psychiatric conditions that impair study engagement
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07160296 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Head and Neck Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07160296 currently recruiting?
Yes, NCT07160296 is actively recruiting participants. Contact the research team at Renown-CRD@renown.org for enrollment information.
Where is the NCT07160296 trial being conducted?
This trial is being conducted at Reno, United States, Reno, United States.
Who is sponsoring the NCT07160296 clinical trial?
NCT07160296 is sponsored by Renown Health. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.